• search hit 14 of 19
Back to Result List

Novel effective fluorinated benzothiophene-indole hybrid antibacterials against S. aureus and MRSA strains

Please always quote using this URN: urn:nbn:de:bvb:20-opus-288253
  • Increasing antibacterial drug resistance threatens global health, unfortunately, however, efforts to find novel antibacterial agents have been scaled back by the pharmaceutical industry due to concerns about a poor return on investment. Nevertheless, there is an urgent need to find novel antibacterial compounds to combat antibacterial drug resistance. The synthesis of novel drugs from natural sources is mostly cost-intensive due to those drugs’ complicated structures. Therefore, it is necessary to find novel antibacterials by simple synthesisIncreasing antibacterial drug resistance threatens global health, unfortunately, however, efforts to find novel antibacterial agents have been scaled back by the pharmaceutical industry due to concerns about a poor return on investment. Nevertheless, there is an urgent need to find novel antibacterial compounds to combat antibacterial drug resistance. The synthesis of novel drugs from natural sources is mostly cost-intensive due to those drugs’ complicated structures. Therefore, it is necessary to find novel antibacterials by simple synthesis to become more attractive for industrial production. We succeeded in the discovery of four antibacterial compound (sub)classes accessible in a simple one-pot reaction based on fluorinated benzothiophene-indole hybrids. They have been evaluated against various S. aureus and MRSA strains. Structure- and substituent-dependent activities have been found within the (sub)classes and promising lead compounds have been identified. In addition, bacterial pyruvate kinase was found to be the molecular target of the active compounds. In conclusion, simple one-pot synthesis of benzothiophene-indoles represents a promising strategy for the search of novel antimicrobial compounds.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Marius Seethaler, Tobias Hertlein, Elisa Hopke, Paul Köhling, Knut Ohlsen, Michael Lalk, Andreas Hilgeroth
URN:urn:nbn:de:bvb:20-opus-288253
Document Type:Journal article
Faculties:Medizinische Fakultät / Institut für Molekulare Infektionsbiologie
Language:English
Parent Title (English):Pharmaceuticals
ISSN:1424-8247
Year of Completion:2022
Volume:15
Issue:9
Article Number:1138
Source:Pharmaceuticals (2022) 15:9, 1138. https://doi.org/10.3390/ph15091138
DOI:https://doi.org/10.3390/ph15091138
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Tag:antibacterial drug resistance; inhibition; structure activity; substituent; synthesis
Release Date:2023/09/08
Date of first Publication:2022/09/13
Licence (German):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International